SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-18-000027
Filing Date
2018-11-05
Accepted
2018-11-05 14:56:36
Documents
57
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amicus-09302018x10q.htm 10-Q 970520
2 EXHIBIT 31.1 fold-09302018xex311.htm EX-31.1 11680
3 EXHIBIT 31.2 fold-09302018xex312.htm EX-31.2 11719
4 EXHIBIT 32.1 fold-09302018xex321.htm EX-32.1 9107
  Complete submission text file 0001178879-18-000027.txt   5638737

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fold-20180930.xml EX-101.INS 1179653
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20180930.xsd EX-101.SCH 36744
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20180930_cal.xml EX-101.CAL 79817
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20180930_def.xml EX-101.DEF 228677
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20180930_lab.xml EX-101.LAB 596987
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20180930_pre.xml EX-101.PRE 353921
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 181159708
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences